The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Stage

Acquired | Acquired

Total Raised

$5.03M

About Pharmagenics

Pharmagenics develops therapeutics products for cancer through the use of genomics therapy.

Pharmagenics Headquarter Location

4 Pearl Court

Allendale, New Jersey, 07401,

United States

201-818-1000

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Pharmagenics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Pharmagenics is included in 2 Expert Collections, including Cancer.

C

Cancer

1,179 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

O

Omics

1,267 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

Latest Pharmagenics News

Genzyme, PharmaGenics shareholders approve acquisition - Boston Business Journal

Jul 17, 2013

Genzyme, PharmaGenics shareholders approve acquisition Jun 16, 1997, 4:03pm EDT Updated Jun 16, 1997, 4:03pm EDT //= $authorImg ?> Save Article Shareholders of Cambridge-based Genzyme Corp. and PharmaGenics Inc. voted to approve the acquisition of PharmaGenics by Genzyme in exchange for approximately 4 million shares, subject to adjustment, of a new Genzyme tracking stock, Genzyme Molecular Oncology. The transaction is expected to close shortly and is valued at approximately $28 million. PharmaGenics develops therapeutic products for cancer through the use of genomics technology. Want Boston news in your inbox? Sign up for our free email newsletters. Suggested Reading

  • Where is Pharmagenics's headquarters?

    Pharmagenics's headquarters is located at 4 Pearl Court, Allendale.

  • What is Pharmagenics's latest funding round?

    Pharmagenics's latest funding round is Acquired.

  • How much did Pharmagenics raise?

    Pharmagenics raised a total of $5.03M.

  • Who are the investors of Pharmagenics?

    Investors of Pharmagenics include Genzyme and Rho Ventures.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.